Coronary Artery Disease Clinical Trials in Milwaukee, Wisconsin

4 studies are recruiting for coronary artery disease in Milwaukee, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Virtue® SAB in the Treatment of Coronary ISR Trial

   A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ascension Columbia St. Mary's Hospital, Milwaukee, Wisconsin

   Locations

   15 in total

   Run by

   Orchestra BioMed, Inc

   See if you can join NCT07045194 on ClinicalTrials.gov

2. SELUTION 4 De Novo Small Vessel IDE Trial

   Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Advocate Aurora St. Luke's, Milwaukee, Wisconsin

   Locations

   70 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05946629 on ClinicalTrials.gov

3. Hybrid Group Singing

   The overall objective of the planned future clinical trial is to test the investigator's central hypothesis that habitual singing over several weeks, similar to habitual exercise, will lead to sustained and favorable vascular adaptation, thereby lowering cardiovascular disease (CVD) risk. The overa…

   Stage

   Not phased

   Ages

   55 to 89

   Site

   Medical College of Wisconsin, Milwaukee, Wisconsin

   Run by

   Medical College of Wisconsin

   See if you can join NCT07355192 on ClinicalTrials.gov

4. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   Ascension Columbia St. Mary's, Milwaukee, Wisconsin

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov